Commentary · 29 Dec 2025
Conference abstract
Antiproteinuric efficacy of Cilnidipine as an add on therapy to Ramipril in patients of Diabetic Kidney Disease.
Himalayan Institute of Medical Sciences, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Diabetic Nephropathy is disabling complication of uncontrolled diabetes mellitus. Clinical proteinuria is a wellestablished marker of renal dysfunction. ACE-I or ARBs are the first choice in the management of proteinuria, but even at the maximum dose they fail to cease the progression of proteinuria.Hence addition of a Calcium channel blocker (CCB) to the already prescribed ACE-I can be used to augment its antiproteinuric effect.Cilnidipine a dual L/N-type CCB dilates the afferent and efferent arterioles of the glomerulus decreasing the intraglomerular pressure and showing antiproteinuric effects.The present study was aimed to study the antiproteinuric efficacy of Cilnidipine as an add on therapy to Ramipril.This interventional study was conducted on 60 patients of both genders aged 18 years and above with diabetic nephropathy (Stage-1 to Stage 4) over a period of one year.Baseline urine protein creatinine ratio (UPCR), serum creatinine and the estimated glomerular filtration rate(eGFR) was recorded and repeated at 12 weeks, after addition of Cilnidipine (5-20 mg) daily dose to the ongoing treatment with Ramipril (2.5-20mg) daily dose. The end point was decrease in the UPCR levels. After 12 weeks of treatment with Cilnidipine, it was observed that there was a significant reduction in the UPCR (mean + SD) from 3.3+1.19 to 3.1+1.05 respectively (p<0.05).The serum creatinine also showed a significant reduction along with an increase in the eGFR levels (p<0.001).This study reveals that the addition of Cilnidipine to Ramipril in patients of Diabetic kidney disease was highly efficacious in preventing the progression of Diabetic nephropathy.
Subjects
SurgeryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Transplantation Technologies & Research.
Brief report · 29 Dec 2025
Transformative Cell & Gene Therapy Innovations
Brief report · 29 Dec 2025
iPSCs: Revolutionizing Biomedical Research and Therapy
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalTransplantation Technologies & Research
- SubjectSurgery
- BylineArticles whose byline prints “Aalia Tausif”
- BylineArticles whose byline prints “Dr. Taruna Sharma”
- BylineArticles whose byline prints “Dr. Shahbaj Ahmad”
- BylineArticles whose byline prints “Dr. Juhi Kalra”
